首页 | 本学科首页   官方微博 | 高级检索  
     

二甲基三十六烷基铵.卡介苗多糖核酸在结核亚单位疫苗中的佐剂效应
引用本文:宋楠楠,王秉翔,史大中,傅林锋,雒彧,于红娟,韩少波,焦磊,郄亚卿,王洪海,张颖,祝秉东. 二甲基三十六烷基铵.卡介苗多糖核酸在结核亚单位疫苗中的佐剂效应[J]. 中华结核和呼吸杂志, 2009, 32(7). DOI: 10.3760/cma.j.issn.1001-0939.2009.07.009
作者姓名:宋楠楠  王秉翔  史大中  傅林锋  雒彧  于红娟  韩少波  焦磊  郄亚卿  王洪海  张颖  祝秉东
作者单位:1. 兰州大学结核病研究中心暨病原生物学研究所,730000
2. 兰州生物制品研究所
3. 复旦大学遗传学研究所
4. Department of Moleular Microbiology and Immunology,Bloomberg School of Pahlic Health,Jolms Hopkins Umvetsiw
基金项目:国家高技术研究发展计划(863计划),科技重大专项课题 
摘    要:目的 探讨二甲基三十六烷基铵(DDA)、卡介苗多糖核酸(BCG-PSN)作为结核病融合蛋白疫苗佐剂的免疫效应.方法 采用热酚法制备BCG-PSN,与DDA联合作为融合蛋白AMM(Ag85B-MPT64190-198-Mth8/4)佐剂免疫小鼠,设卡介苗、生理盐水、弗氏不完全佐剂(IFA)及单独应用DDA或BCG-PSN一种佐剂的各组作为对照.应用ELISA和酶联免疫斑点法检测免疫小鼠的体液与细胞免疫反应.结果 分离培养疫苗免疫小鼠的脾脏淋巴细胞,用特异性抗原AgSSB刺激后,AMM+DDA+BCG-PSN疫苗组、AMM+DDA组和卡介苗组小鼠每1×106个脾淋巴细胞分泌γ-干扰素的细胞数分别为222±79、259±85和230±64,均明显高于AMM+PBS组(40±4)、AMM+IFA组(10 ±3)、AMM+BCG-PSN组(132±18)和生理盐水组(8±4),差异有统计学意义(t值为2.923~7.118,均P<0.05);与单用DDA组比较,添加DDA和BCG-PSN两种佐剂的疫苗组小鼠血清抗体滴度Ig2a/IgG1较高(0.125和0.025),但γ-干扰素分泌水平没有增高.结论 AMM+DDA+BCG-PSN结核病亚单位疫苗能够引起较强的Th1细胞免疫为主的免疫反应,DDA+BCG-PSN(尤其是DDA)具有增强结核病亚单位疫苗Th1细胞免疫应答的佐剂效应.

关 键 词:分枝杆菌,结核  疫苗,亚单位  卡介苗

Dimo-thylidioctyl ammonium bromide-BCG polysaccharide nucleic acid adjuvant enhanced the immtmogenicity of a Mycobacterium tuberculosis subunit vaccine
SONG Nan-nan,WANG Bing-xiang,SHi Da-zhong,FU Lin-feng,LUO Yu,YU Hong-juan,HAN Shao-bo,JIAO Lei,QIE Ya-qing,WANG Hong-hai,ZHANG Ying,ZHU Bing-dong. Dimo-thylidioctyl ammonium bromide-BCG polysaccharide nucleic acid adjuvant enhanced the immtmogenicity of a Mycobacterium tuberculosis subunit vaccine[J]. Chinese journal of tuberculosis and respiratory diseases, 2009, 32(7). DOI: 10.3760/cma.j.issn.1001-0939.2009.07.009
Authors:SONG Nan-nan  WANG Bing-xiang  SHi Da-zhong  FU Lin-feng  LUO Yu  YU Hong-juan  HAN Shao-bo  JIAO Lei  QIE Ya-qing  WANG Hong-hai  ZHANG Ying  ZHU Bing-dong
Abstract:Objective To investigate the activity of a novel adjuvant consisting of dimethyl-dioctyldecyl ammonium bromide (DDA) and BCG polysaccharide nucleic acid (BCG-PSN). Methods BCG-PSN was extracted by hot-phenol method, and combined with DDA and Mycobacterium tuberculosis fusion antigen AMM (Ag85B-MPT64190-198-Mtb8.4) to formulate the Mycobacterium tuberculosis subunit vaccine. Mice were iannunized subcutaneously with a 2-week interval between the immunizations (0. 2 ml/ dose), and humoral and cell-mediated immunity were detected by ELISA and ELISPOT respectively. Results With the stimulation of Ag85B in vitro, the number of antigen specific IFN-γ producing spleen lymphocytes were 222 ± 79,259 ± 85,230 ± 64 per million respectively in the mice immunized with AMM + DDA + BCG-PSN, AMM + DDA, and BCG. Spleen lymphocytes in these 3 groups produced higher levels of IFN-γ compared to the groups with the adjuvant of IFA or BCG-PSN alone or without adjuvant upon stimulation with Ag85B (t = 2.923 - 7. 118, P < 0.05). Furthermore, the adjuvant consisting of DDA and BCG-PSN increased the ratio of Ig2a/IgG1 than DDA alone (0. 125 vs 0. 025). Combined with AMM, the adjuvant DDA and the one consisting of DDA and BCG-PSN induced higher level of immunity than incomplete Freund' s adjuvant (IFA), NaCl, and BCG-PSN alone. Conclusion Mycobacterium tuberculosis subunit vaccine AMM + DDA + BCG-PSN induced a strong Thl-type immune response, and DDA + BCG-PSN, especially DDA promoted the immune response of the M. tuberculosis subunit vaccine in mice.
Keywords:Mycobacterium tuberculosis  Vaccine subunit  BCG vaccine
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号